Who owns Antares Pharma?

Key details on Antares Pharma (Ticker: AIS)

Who owns Antares Pharma?

Is AIS a good stock to own? Find out who bought Antares Pharma, who sold Antares Pharma (AIS) stock, and who holds a large position in Antares Pharma.

Fund Name Number of Shares Share Valuation As Of
Deerfield Management Company 12.08M $32.73M March 31, 2015
Broadfin Capital 4.70M $12.08M Dec. 31, 2014
Vanguard 4.26M $11.53M March 31, 2015
BlackRock Institutional Trust Company, N.A. 3.97M $10.76M March 31, 2015
Millennium Management 3.44M $6.30M Sept. 30, 2014
BlackRock Fund Advisors 3.31M $8.96M March 31, 2015
OrbiMed Advisors 3.21M $11.25M March 31, 2014
ARMISTICE CAPITAL 2.60M $6.68M Dec. 31, 2014
WEISS MULTI-STRATEGY ADVISERS 1.91M $4.21M Dec. 31, 2011
STATE STREET CORPORATION 1.91M $5.17M March 31, 2015
Allianz Asset Management AG 1.84M $6.42M March 31, 2014
William Harris Investors 1.54M $4.18M March 31, 2015
WEISS MULTI-STRATEGY ADVISERS 1.30M $4.20M March 31, 2012
NORTHERN TRUST 1.27M $3.44M March 31, 2015
Kingdon Capital Management 1.17M $3.16M March 31, 2015
Thomson Horstmann & Bryant, Inc." 1.12M $4.54M Sept. 30, 2013
Ghost Tree Capital 1.10M $2.01M Sept. 30, 2014
Ashford Capital Management 1.09M $2.91M June 30, 2014
PUTNAM INVESTMENTS 1.07M $3.75M March 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.02M $2.73M June 30, 2014
J. Goldman & Co 973572 $3.41M March 31, 2014

Who sold Antares Pharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
VHCP Management Sept. 30, 2011 2.10M $4.87M
Allianz Global Investors of America Sept. 30, 2011 996100 $2.31M
Eudaimonia Asset Management Sept. 30, 2011 920321 $2.14M
J P MORGAN CHASE & CO Dec. 31, 2010 1.15M $1.96M